Novel alpha interferon (IFN-alpha) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-alpha2b therapy in a subgenomic replicon system

在亚基因组复制子系统中，与IFN-α2b疗法相比，新型α干扰素（IFN-α）变体对丙型肝炎病毒基因1型复制具有更强的抑制活性。